Sims Melissa Kaye reported grant involving 4,170 shares of IMPACT BIOMEDICAL INC. at $4.54 for −$18.9k on Oct 7, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Nov 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$18,931.80Shares × reported price
Shares traded
4,170Common Stock
Price per share
$4.54Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
32,112Direct
Trade date
Oct 7, 2026Grant
Filed
Nov 5, 2026, 5:53 PM ET29-day reporting delay
Accession
0001493152-26-050293Code A · Transaction 393971
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 29 calendar days after the transaction date.

IBO price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
IBO · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago +56%1d ago +30%
Returns since7d +32%30d90d180d1y

Footnotes in full

No footnotes recorded. Check the original SEC filing for the complete report.